
Medicine and Health
Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
Y. Hagihara, A. Sakamoto, et al.
Discover the groundbreaking potential of the photoactivatable oncolytic adenovirus (paOAd), engineered by Yasuko Hagihara and team, to revolutionize cancer therapy. This innovative approach harnesses blue light to activate the virus, leading to remarkable tumor growth inhibition without harmful side effects when not triggered. A leap forward in targeting even the most resilient cancer stem cells.
~3 min • Beginner • English
Related Publications
Explore these studies to deepen your understanding of the subject.